Keyword: National Institutes of Health (NIH)
A small private biotech has raised a modest series B as it continues to test its idea that the memory-wasting disease can be beaten back by focusing o
The goal is to start testing in vivo gene-based treatments for the diseases in humans within 10 years.
As the industry’s digital transformation is fueled by tools such as AI and machine learning, certain R&D projects promise to have outsized impacts.
NCATS aims to bring together disparate data sets from across the healthcare enterprise to communicate the patient's story in a different way.
The consortium intends to make new tools, models and processes broadly available, with a large focus on solutions geared toward cancer patients.
As the biopharma industry’s digital transformation continues apace, with the rapid acceptance of tools such as artificial intelligence and machine learning, certain projects promise to yield impacts on a much wider scale.
The $3 billion funding boost includes an additional $350 million for targeted Alzheimer’s research.
The RV144 HIV vaccine regimen containing clades B and E inserts produced strong immune responses in South Africa, where clade C dominates.
Researchers are hoping to one day circumvent the retinas of people with age-related macular degeneration and progressive blindness.
The National Institutes of Health has tapped the genomics firm Color to help participants understand and act on their results.